NCT01188577View on ClinicalTrials.gov

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

January 31, 2011

Conditions
AsthmaBronchospasmWheezingShortness of Breath
Interventions
DRUG

Epinephrine Inhalation Aerosol, HFA

10 inhalations of epinephrine inhalation aerosol, 125 mcg/inhalation

DRUG

Epinephrine Inhalation Aerosol

Epinephrine Inhalation Aerosol, 220 mcg/ inhalation, 10 inhalations

Trial Locations (1)

90630

Amphastar Site 0035, Cypress

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY